Clinical Trial

Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.

Name: Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. — clinical trial record (NCT07396337)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the efficacy and safety of QHRD106 injection in treating acute ischemic stroke.

Trial Details

NCT Number	NCT07396337
Lead Sponsor	Changzhou Qianhong Bio-pharma Co., Ltd.
Conditions	Acute Ischemic Stroke
Enrollment	320 participants
Start Date	2026-01-19
Primary Completion	2026-10-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-09